Vanguard Investments Australia’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vanguard Investments Australia's BMY Position: Q2 2026 in Review
Vanguard Investments Australia increased its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2026, buying an estimated $1.68M and bringing the position to 1,044,439 shares worth $60.2M. The position accounts for 0.15% of the portfolio, ranked #123.
Vanguard Investments Australia first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $61.6M in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vanguard Investments Australia held 1,044,439 shares of Bristol-Myers Squibb worth $60.2M as of Q2 2026.
- Vanguard Investments Australia bought 29,178 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.68M.
- Bristol-Myers Squibb made up 0.15% of Vanguard Investments Australia's portfolio in Q2 2026, its #123 holding.
- Vanguard Investments Australia first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Vanguard Investments Australia's Bristol-Myers Squibb position peaked at $61.6M in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.